摘要The mitochondrial genomic homeostasis is essential for the function of the oxidative phosphorylation system and cellular homeostasis.Mitochondrial DNA is particularly susceptible to aging-related oxidative stress due to the lack of a histone coat.Disturbances in mitochondrial DNA may contribute to functional decline during the aging process and in neurodegenerative diseases,leading to further impairment of mitochondrial DNA and initiating a vicious cycle.To date,it remains unclear how disturbed mitochondrial DNA is involved in the etiology of pathological aging and neurodegenerative diseases.The purpose of this review is to clarify the crucial roles of mitochondrial DNA homeostasis in the pathogenesis of neurodegenerative diseases.Mitochondrial DNA is distributed within nucleoids and is then transcribed into polycistronic mitochondrial DNA molecules within the mitochondrial granule region.Within the ultrastructure of the mitochondrial nucleoid and granule,a group of essential mitochondrial proteins involved in DNA replication,DNA transcription,RNA translation,RNA surveillance,and RNA degradation plays a crucial role in maintaining mitochondrial structure,genome integrity,and mitochondrial DNA processing.The uniparentally inherited mitochondrial DNA undergoes heritable polyploid variations,which include homoplasmy and heteroplasmy.Accumulating mitochondrial DNA alterations,such as deletions,point mutations,and methylations,occur during the pathogenic processes of neurodegenerative diseases.The increased mitochondrial DNA alterations can be propagated by the rise of deleterious heteroplasmy in neurodegenerative diseases,ultimately resulting in impairment to the oxidative phosphorylation system,biogenesis defects,and cellular metabolic dysfunction.Therefore,developing appropriate gene editing tools to rectify aberrant alterations in mitochondrial DNA and targeting the key proteins involved in maintaining mitochondrial DNA homeostasis can be considered promising therapeutic strategies for neurodegenerative diseases.Although therapeutic strategies targeting mitochondrial DNA in diseases show great potential,challenges related to efficacy and safety require a better understanding of the mechanisms underlying mitochondrial DNA alterations in aging and neurodegenerative diseases.